国家自然科学基金高血压中医药研究资助情况分析

Analysis on Funding Situation about Study on TCM for Hypertension by National Natural Science Foundation of China

目的了解国家自然科学基金资助高血压中医药研究项目的现状与趋势。方法检索国家自然科学基金委员会项目综合查询中1997-2018年资助的H27(中医学)、H28(中药学)和H29(中西医结合)领域的高血压研究项目,统计批准年度、学科领域、资助类别、依托单位、研究内容,进行归纳分析。结果国家自然科学基金对高血压中医药研究的立项资助自1999年起,至2018年累计资助94项,资助总金额3901万元,其中面上项目58项共计2999万元,地区科学基金10项共计369万元,青年科学基金26项共计533万元。资助项目数最多的分支学科为H2708(中医内科)和H2902(中西医结合临床基础),均为26项,且资助金额均大于1000万元。获得资助的94项课题来自35家依托单位,其中获资助最多者为山东中医药大学(15项)。研究疾病以高血压疾病最多(48.94%),研究对象以中药复方最多(42.55%),研究指标以通路最多(35.11%)。结论国家自然科学基金对高血压中医药研究的资助力度较大,但发展不均,各单位应从不同方向积极申报。

Objective To understand the current situation and trend of the hypertension research project of TCM funded by National Natural Science Foundation of China(NSFC).Methods Research projects in the fields of H27(TCM),H28(science of Chinese materia medica)and H29(integrated traditional Chinese and Western medicine)funded by the project comprehensive inquiry of NSFC from 1997 to 2018 were retrieved through the Internet.Approval year,subject areas,funding categories,support organizations,and research contents were summarized and analyzed.Results NSFC funded 94 research projects on TCM for hypertension from 1999 to 2018,with a total amount of 39.01 million yuan.58 surface funds accounted for 29.99 million yuan,10 regional funds 3.69 million yuan,and 26 youth funds 5.33 million yuan.H2708(internal medicine of TCM)and H2902(clinical basis of integrated traditional Chinese and Western medicine)were subdisciplines with the most funds,each of which was 26 and the amount of money was more than 10 million yuan.94 projects were funded from 35 supporting organizations,of which Shandong University of TCM(15)received the most funding.In terms of the study of diseases,hypertension was with the highest frequency,accounting for 48.94%;in terms of the object of study,TCM compound was with the highest frequency,accounting for 42.55%;in terms of the research index,the path research was with the highest frequency,accounting for 35.11%.Conclusion The NSFC shows strong financial support to the research of TCM in hypertension,but the development is uneven.All units should actively apply from different directions.